Old Web
English
Sign In
Acemap
>
authorDetail
>
Calin Dan Dumitru
Calin Dan Dumitru
Merck & Co.
Biology
Immunology
Agonist
Immune system
Immunotherapy
4
Papers
144
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study.
2011
mAbs
Ningyan Zhang
Liming Liu
Calin Dan Dumitru
Nga Rewa Houston Cummings
Michael Cukan
Youwei Jiang
Yuan Li
Fang Li
Teresa I. Mitchell
Muralidhar R. Mallem
Yangsi Ou
Rohan Patel
Kim Vo
Hui Wang
Irina Burnina
Byung-Kwon Choi
Hans E. Huber
Terrance A. Stadheim
Dongxing Zha
Show All
Source
Cite
Save
Citations (78)
Potentiation of the anti-tumor effects of imidazoquinoline immune response modifiers by cyclophosphamide.
2010
Cancer Biology & Therapy
Calin Dan Dumitru
Mary A. Antonysamy
Mark A. Tomai
Kenneth E. Lipson
Show All
Source
Cite
Save
Citations (16)
NK1.1+ cells mediate the antitumor effects of a dual Toll-like receptor 7/8 agonist in the disseminated B16-F10 melanoma model
2009
Cancer Immunology, Immunotherapy
Calin Dan Dumitru
Mary A. Antonysamy
Kevin S. Gorski
Dave D. Johnson
Laxma Reddy
Jody L. Lutterman
Melissa M. Piri
Joel Proksch
Sean M. McGurran
Elaine A. Egging
Felicia R. Cochran
Kenneth E. Lipson
Mark A. Tomai
Gary W. Gullikson
Show All
Source
Cite
Save
Citations (24)
TLR7 Agonist 852A Inhibition of Tumor Cell Proliferation Is Dependent on Plasmacytoid Dendritic Cells and Type I IFN
2008
Journal of Interferon and Cytokine Research
Jon R. Inglefield
Calin Dan Dumitru
Sefik S. Alkan
Sheila J. Gibson
Kenneth E. Lipson
Mark A. Tomai
Chris J. Larson
John P. Vasilakos
Show All
Source
Cite
Save
Citations (26)
1